These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevalence and Risk Factors of Clostridium difficile Infection Among Patients Hospitalized for a Flare of Inflammatory Bowel Disease in King Abdulaziz University Hospital. Samman AA; Alfares M; Bajabur RA; Alnefaie RO; Alwadai LS; Murad WW; Dahal BM Cureus; 2023 Nov; 15(11):e48451. PubMed ID: 38074066 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and Factors Associated with Treatment Response of Intravenous Immunoglobulin in Inpatients with Refractory Inflammatory Bowel Diseases. Horton N; Kochhar G; Patel K; Lopez R; Shen B Inflamm Bowel Dis; 2017 Jul; 23(7):1080-1087. PubMed ID: 28452863 [TBL] [Abstract][Full Text] [Related]
25. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711 [TBL] [Abstract][Full Text] [Related]
26. Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis. Anderson A; Click B; Ramos-Rivers C; Cheng D; Babichenko D; Koutroubakis IE; Hashash JG; Schwartz M; Swoger J; Barrie AM; Dunn MA; Regueiro M; Binion DG Inflamm Bowel Dis; 2017 Dec; 23(12):2180-2188. PubMed ID: 29084081 [TBL] [Abstract][Full Text] [Related]
27. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program. Chopra T; Neelakanta A; Dombecki C; Awali RA; Sharma S; Kaye KS; Patel P Am J Infect Control; 2015 Apr; 43(4):314-7. PubMed ID: 25838133 [TBL] [Abstract][Full Text] [Related]
28. Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial. Gawronska A; Banasiuk M; Lachowicz D; Pituch H; Albrecht P; Banaszkiewicz A Inflamm Bowel Dis; 2017 Dec; 23(12):2209-2214. PubMed ID: 29084080 [TBL] [Abstract][Full Text] [Related]
29. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. Li Y; Qian J; Queener E; Shen B Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770 [TBL] [Abstract][Full Text] [Related]
30. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384 [TBL] [Abstract][Full Text] [Related]
31. Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease. Pant C; Anderson MP; Deshpande A; Altaf MA; Grunow JE; Atreja A; Sferra TJ Inflamm Bowel Dis; 2013 Apr; 19(5):1080-5. PubMed ID: 23478808 [TBL] [Abstract][Full Text] [Related]
32. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship. Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522 [TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. Navaneethan U; Mukewar S; Venkatesh PG; Lopez R; Shen B J Crohns Colitis; 2012 Apr; 6(3):330-6. PubMed ID: 22405170 [TBL] [Abstract][Full Text] [Related]
34. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734 [TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades. Moens A; Verstockt B; Machiels K; Bossuyt P; Verdonck A; Lagrou K; van Assche G; Vermeire S; Ferrante M Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):668-673. PubMed ID: 30839436 [TBL] [Abstract][Full Text] [Related]
36. Comparison of testing approaches for Clostridium difficile infection at a large community hospital. Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523 [TBL] [Abstract][Full Text] [Related]
37. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results. Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930 [TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting. Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169 [TBL] [Abstract][Full Text] [Related]
40. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Jarvis WR; Schlosser J; Jarvis AA; Chinn RY Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]